Skip to main content

Advertisement

Springer Nature Link
Log in

Quality of analgesic treatment in patients with advanced prostate cancer: do we do a better job now? The Swiss Group for Clinical Cancer Research (SAKK) experience

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Goals of work

The aim of this study was to evaluate pain intensity and the application of the WHO guidelines for cancer pain treatment in patients with prostate cancer treated at Swiss cancer centers.

Materials and methods

We analyzed a series of five multicenter phase II clinical trials which examined the palliative effect of different chemotherapies in patients with advanced hormone-refractory prostate carcinoma. Of 170 patients, 1,018 visits were evaluable for our purpose, including ratings of pain intensity by patients and prescribed analgesics.

Main results

No or mild pain was indicated by patients in 36 to 55% of the visits, more than mild pain in 30 to 46%. In 21% of the visits, the WHO pain treatment criteria (treatment according to one of the three steps; oral, rectal or transdermal application of the main dose; administration on a regular schedule) were fulfilled, and the Cleeland index was positive according to all recommendations. In 6% of the visits, neither the WHO criteria were fulfilled nor was the Cleeland index positive. This indicates insufficient pain treatment not following the WHO guidelines and that the prescribed analgesics were not sufficiently potent for the rated pain intensity.

Conclusions

In this selective Swiss sample, the standard of analgesic treatment is high. However, there is still scope for improvement. This cannot solely be solved by improving the knowledge of the physicians. Programs to change the patients’ attitude towards cancer pain, training to improve the physicians’ communication skills, and institutional changes may be promising strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brescia FJ, Portenoy RK, Ryan M, Krasnoff L, Gray G (1992) Pain, opioid use, and survival in hospitalized patients with advanced cancer. J Clin Oncol 10:149–155

    PubMed  CAS  Google Scholar 

  2. Bruera E, Navigante A, Barugel M, Macmillan K, Macdonald RN, Chacon R (1990) Treatment of pain and other symptoms in cancer patients: patterns in a North American and a South American hospital. J Pain Symptom Manage 5:78–82

    Article  PubMed  CAS  Google Scholar 

  3. Calais Da Silva F, Reis E, Costa T, Denis L (1993) Quality of life in patients with prostatic cancer. A feasibility study. Cancer 71:1138–1142

    Article  Google Scholar 

  4. Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA et al (1994) Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 330:592–596

    Article  PubMed  CAS  Google Scholar 

  5. Curran D, Fossa S, Aaronson N, Kiebert G, Keuppens E, Hall R (1997) Baseline quality of life of patients with advanced prostate cancer. Eur J Cancer 33:1809–1814

    Article  PubMed  CAS  Google Scholar 

  6. Dorrepaal KL, Aaronson NK, Van Dam FSAM (1989) Pain experience and pain management among hospitalized cancer patients, a clinical study. Cancer 63:593–598

    Article  PubMed  CAS  Google Scholar 

  7. Elsner F, Sonntag B, Schmeisser N, Kiencke P, Sabatowski R, Loick G et al (2002) Application of guidelines for the treatment of headache and cancer pain by private practitioners. Schmerz 16(1):41–47

    Article  PubMed  CAS  Google Scholar 

  8. Foley KM (1995) Pain relief into practice: rhetoric without reform. J Clin Oncol 13:2149–2151

    PubMed  CAS  Google Scholar 

  9. Fosså SD, Aaronson NK, Newling D, van Cangh PJ, Denis L, Kurth KH et al (1990) Quality of life and treatment of hormone resistant metastatic prostatic cancer. Eur J Cancer 26:1133–1136

    Article  PubMed  Google Scholar 

  10. Greco PJ, Eisenberg JM (1993) Changing physicians’ practices. N Engl J Med 329:1271–1274

    Article  PubMed  CAS  Google Scholar 

  11. Heim H, Oei TPS (1993) Comparison of prostate cancer patients with and without pain. Pain 53:159–162

    Article  PubMed  CAS  Google Scholar 

  12. Hölzel D (1991) Epidemiologie des Prostatakarzinoms. Fortschr Med 26:521–525

    Google Scholar 

  13. Jadad AR, Browman GP (1995) The WHO analgesic ladder for cancer pain management, stepping up the quality of its evaluation. JAMA 274:1870–1873

    Article  PubMed  CAS  Google Scholar 

  14. Johansson JE, Andersson SO, Krusemo UB, Adami HO, Bergström R, Kraaz W (1989) Natural history of localised prostatic cancer. Lancet 1:799–803

    Article  PubMed  CAS  Google Scholar 

  15. Jungi WF, Bernhard J, Hürny C, Shu Schmitz S, Hanselmann S, Gusset H et al (1998) Effect of carboplatin on response and palliation in hormone-refractory prostate cancer. Support Care Cancer 6:462–468

    Article  PubMed  CAS  Google Scholar 

  16. Kornblith AD, Herr HW, Ofman US, Scher HI, Holland JC (1994) Quality of life of patients with prostate cancer and their spouses. The value of a data base in clinical care. Cancer 73:2791–2802

    Article  PubMed  CAS  Google Scholar 

  17. Levi F, La Vecchia C (2002) The epidemiology of prostate cancer. Prostatakrebs—Fakten und Handlungsbedarf. Bundesamt für Gesundheit und Krebsliga Schweiz, Bern, pp 5–9

    Google Scholar 

  18. Larue F, Colleau SM, Brasseur L, Cleeland CS (1995) Multicentre study of cancer pain and its treatment in France. BMJ 310:1034–1037

    PubMed  CAS  Google Scholar 

  19. Max MB (1990) Improving outcomes of analgesic treatment, is education enough? Ann Intern Med 113:885–889

    PubMed  CAS  Google Scholar 

  20. Morant R, Bernhard J, Maibach R, Borner M, Fey MF, Thürlimann E et al (2000) Response an palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma. Ann Oncol 11:183–188

    Article  PubMed  CAS  Google Scholar 

  21. Morant R, Bernhard J, Dietrich D, Gillessen S, Bonomo M, Borner M et al (2004) Capecitabine in hormone-resistant metastatic prostatic carcinoma—a phase II trial. Br J Cancer 90:1312–1317

    Article  PubMed  CAS  Google Scholar 

  22. Morant R, Hsu Schmitz SF, Bernhard J, Thürlimann B, Borner M, Wernli M et al (2002) Vinorelbine in androgen-independent metastatic prostatic carcinoma—a phase II study. Eur J Cancer 38:1626–1632

    Article  PubMed  CAS  Google Scholar 

  23. Pollen J, Schmidt JD (1979) Bone pain in metastatic cancer of prostate. Urology 13:129–134

    Article  PubMed  CAS  Google Scholar 

  24. Schmid HP, Maibach R, Bernhard J, Hering F, Hanselmann S, Gusset H et al (1997) A phase II study of oral idarubicin as a treatment for metastatic hormone-refractory prostate carcinoma with special focus on prostate specific antigen doubling time. Cancer 79:1703–1709

    Article  PubMed  CAS  Google Scholar 

  25. Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS (1995) When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 61:277–284

    Article  PubMed  CAS  Google Scholar 

  26. Thalmann G, Anezinis P, Devoll R, Farach-Carson C, Chung LWK (1997) Experimental approaches to skeletal metastasis of human prostate cancer. principles and practice of genitourinary oncology. Lippincott-Raven Publishers, Philadelphia, pp 409–416

    Google Scholar 

  27. Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F (1987) A validation study of the WHO method for cancer pain relief. Cancer 59:850–856

    Article  PubMed  CAS  Google Scholar 

  28. Vuorinen E, Vainio A, Reponen A (1997) Backlash in the treatment of cancer pain: use of opioid analgesics in a Finnish general hospital in 1987, 1991 and 1994. J Pain Symptom Manage 14:286–291

    Article  PubMed  CAS  Google Scholar 

  29. Walsh PC (1998) The natural history of localized prostate cancer: a guide to therapy. Campbell’s urology, 7th edn. Saunders, Philadelphia, pp 2539–2546

    Google Scholar 

  30. Ward SE, Goldberg N, Miller-McCauley V, Mueller C, Nolan A, Pawlik-Plank D et al (1993) Patient-related barriers to management of cancer pain. Pain 52:319–324

    Article  PubMed  CAS  Google Scholar 

  31. Zech DFJ, Grond S, Lynch J, Hertel D, Lehmann KA (1995) Validation of World Health Organization guidelines for cancer pain relief: a 10 year prospective study. Pain 63:65–76

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Bürgerspital, Schöngrünstrasse 38a, 4500, Solothurn, Switzerland

    C. Münger-Beyeler

  2. Department of Medical Oncology, Inselspital, 3010, Bern, Switzerland

    J. Bernhard

  3. Swiss Group for Clinical Cancer Research, Effingerstr. 40, 3008, Bern, Switzerland

    J. Bernhard & K. Rufibach

  4. Center for Tumor Detection and Prevention ZeTuP, Rorschacherstrasse 150, 9006, St. Gallen, Switzerland

    R. Morant

  5. Department of Urology, Kantonsspital, Rorschacherstrasse 95, 9007, St. Gallen, Switzerland

    H.-P. Schmid

  6. Benteliweg 3, 3018, Bern, Switzerland

    C. Münger-Beyeler

Authors
  1. C. Münger-Beyeler
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. J. Bernhard
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. K. Rufibach
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. R. Morant
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. H.-P. Schmid
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to C. Münger-Beyeler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Münger-Beyeler, C., Bernhard, J., Rufibach, K. et al. Quality of analgesic treatment in patients with advanced prostate cancer: do we do a better job now? The Swiss Group for Clinical Cancer Research (SAKK) experience. Support Care Cancer 16, 461–467 (2008). https://doi.org/10.1007/s00520-007-0335-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-007-0335-7

Keywords